Table of Contents
PPT Slide
Celltech - A European biotechnology leader
Celltech - Pipeline Highlights
Celltech - an innovative competitive pipeline
CDP 870 - 3rd generation anti-TNF? therapy for RA and Crohn’s
CDP 870: Phase II results in rheumatoid arthritis*
CDP 870: Phase II results in rheumatoid arthritis
CDP 870: Phase II studies in Crohn’s disease
CDP 870: Overview of Ph II results in Crohn’s
CDP 870 - Pharmacia Partnership
Humicade™: New anti-TNF? therapy for Crohn’s disease
Celltech-Merck collaboration: phosphodiesterase 4 inhibitor for respiratory disease
BMS275291: selective matrix metalloproteinase inhibitor in cancer chemotherapy
Celltech - Financial Results
Celltech - Pharma sales
Celltech - Pharma
Celltech - Royalties
Celltech - Genentech Boss/Cabilly settlement
Restructuring expenditure
Celltech - a European biotechnology leader
PPT Slide
|